373 related articles for article (PubMed ID: 24220639)
1. Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients.
Huang WH; Chen HL; Huang PH; Yew TL; Lin MW; Lin SJ; Hung SC
Cardiovasc Res; 2014 Feb; 101(2):266-76. PubMed ID: 24220639
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
[TBL] [Abstract][Full Text] [Related]
3. Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method.
Ishii M; Shibata R; Numaguchi Y; Kito T; Suzuki H; Shimizu K; Ito A; Honda H; Murohara T
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2210-5. PubMed ID: 21757660
[TBL] [Abstract][Full Text] [Related]
4. Macrophages regulate smooth muscle differentiation of mesenchymal stem cells via a prostaglandin F₂α-mediated paracrine mechanism.
Lee MJ; Kim MY; Heo SC; Kwon YW; Kim YM; Do EK; Park JH; Lee JS; Han J; Kim JH
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2733-40. PubMed ID: 22962328
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of human embryonic stem cell-derived endothelial cells in humanized mouse models harboring a human immune system.
Yang HM; Moon SH; Choi YS; Park SJ; Lee YS; Lee HJ; Kim SJ; Chung HM
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2839-49. PubMed ID: 24092748
[TBL] [Abstract][Full Text] [Related]
6. Unsorted human adipose tissue-derived stem cells promote angiogenesis and myogenesis in murine ischemic hindlimb model.
Kang Y; Park C; Kim D; Seong CM; Kwon K; Choi C
Microvasc Res; 2010 Dec; 80(3):310-6. PubMed ID: 20510252
[TBL] [Abstract][Full Text] [Related]
7. Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.
Ma Q; Xia X; Tao Q; Lu K; Shen J; Xu Q; Hu X; Tang Y; Block NL; Webster KA; Schally AV; Wang J; Yu H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):663-672. PubMed ID: 26868211
[TBL] [Abstract][Full Text] [Related]
8. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.
Lee JH; Lee SH; Yoo SY; Asahara T; Kwon SM
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1622-34. PubMed ID: 23640491
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
10. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.
Kinnaird T; Stabile E; Burnett MS; Shou M; Lee CW; Barr S; Fuchs S; Epstein SE
Circulation; 2004 Mar; 109(12):1543-9. PubMed ID: 15023891
[TBL] [Abstract][Full Text] [Related]
11. Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism.
Rossi E; Smadja D; Goyard C; Cras A; Dizier B; Bacha N; Lokajczyk A; Guerin CL; Gendron N; Planquette B; Mignon V; Bernabéu C; Sanchez O; Smadja DM
Thromb Haemost; 2017 Oct; 117(10):1908-1918. PubMed ID: 28771278
[TBL] [Abstract][Full Text] [Related]
12. Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels.
Choi M; Lee HS; Naidansaren P; Kim HK; O E; Cha JH; Ahn HY; Yang PI; Shin JC; Joe YA
Int J Biochem Cell Biol; 2013 Mar; 45(3):560-70. PubMed ID: 23246593
[TBL] [Abstract][Full Text] [Related]
13. Stro-1-positive human mesenchymal stem cells prolong skin graft survival in mice.
Zhang Y; Zhao D; Tian C; Li F; Li X; Zhang L; Yang H
Transplant Proc; 2013 Mar; 45(2):726-9. PubMed ID: 23498813
[TBL] [Abstract][Full Text] [Related]
14. Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.
Koyanagi M; Iwasaki M; Rupp S; Tedesco FS; Yoon CH; Boeckel JN; Trauth J; Schütz C; Ohtani K; Goetz R; Iekushi K; Bushoven P; Momma S; Mummery C; Passier R; Henschler R; Akintuerk H; Schranz D; Urbich C; Galvez BG; Cossu G; Zeiher AM; Dimmeler S
Circ Res; 2010 Apr; 106(7):1290-302. PubMed ID: 20185800
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia.
Ishii M; Numaguchi Y; Okumura K; Kubota R; Ma X; Murakami R; Naruse K; Murohara T
Atherosclerosis; 2009 Sep; 206(1):109-18. PubMed ID: 19344900
[TBL] [Abstract][Full Text] [Related]
16. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
17. Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kang D; Chang JW; Choi SW; Kang KS; Kim DI
Tissue Cell; 2017 Dec; 49(6):680-690. PubMed ID: 28958480
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase-2 is a host factor required for effective bone marrow mesenchymal stem cell therapy.
Zhu H; Sun A; Zhu H; Li Z; Huang Z; Zhang S; Ma X; Zou Y; Hu K; Ge J
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):894-901. PubMed ID: 24558108
[TBL] [Abstract][Full Text] [Related]
19. Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis.
Tepeköylü C; Wang FS; Kozaryn R; Albrecht-Schgoer K; Theurl M; Schaden W; Ke HJ; Yang Y; Kirchmair R; Grimm M; Wang CJ; Holfeld J
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):971-8. PubMed ID: 23395097
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
